Quest Diagnostics Incorporated
NYSEDGX short interest tumbles 25.4% in one week to 2.94% of float, marking pullback from recent highs as cost to borrow holds steady at 0.45%.
DGX heads into tomorrow's Q2 print with the options market flipping dramatically from caution to confidence — a sharp reversal from the defensive posture described in the preview published just four days ago. The most…
DGX reports second-quarter results on July 21 with options traders striking their most defensive posture in months — even as short sellers quietly retreat from the name. The clearest pre-earnings signal is in the…
Snapshot as of 9 Aug 2026
Quest Diagnostics enters its July 21 earnings window with short sellers quietly retreating and options traders leaning more bullish than usual — a modest but consistent tilt toward the constructive side heading into…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DGX — free to start on ORTEX.
Sign up for free →Open DGX on ORTEX